RepRegenâ„¢ Reports Potential Advance In The Repair And Regeneration Of Hard-Tissue, Such As Bone
RepRegenâ„¢, the 'smart biomaterials' company previously known as BioCeramic Therapeutics, announced today that data from an in vitro study has demonstrated that its patented Strontium-based bioactive glass platform promotes osteoblast cell activity and proliferation. If in vivo studies, which are currently underway, demonstrate similar results, then RepRegen believes its platform has the potential to significantly improve the repair and regeneration of hard-tissue, such as bone... <p><a href="http://feedads.g.doubleclick.net/~a/fEMlf8nBuiAjgRmgyBxH9GT42Iw/0/da"><img src="http://feedads.g.doubleclick.net/~a/fEMlf8nBuiAjgRmgyBxH9GT42Iw/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/fEMlf8nBuiAjgRmgyBxH9GT42Iw/1/da"><img src="http://feedads.g.doubleclick.net/~a/fEMlf8nBuiAjgRmgyBxH9GT42Iw/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/CZqUPQKBnlk" height="1" width="1"/>
Published: Tue, 09 Mar 2010 21:00:00 PST by

FDA Clears biospace med's SterEOS 2D/3D Workstation For Pediatric Use In Spine
biospace med announced today that it has received 510(k) clearance from the FDA (Food and Drug Administration) to market the Company's sterEOS 2D/3D workstation for pediatric use in spine applications. The Company's EOS ultra-low-dose imager previously has been FDA-cleared for use in pediatrics and adults, while sterEOS has previously been FDA-cleared for adult use in spine... <p><a href="http://feedads.g.doubleclick.net/~a/dFiePBf59UpV8F4eQkdycuUtwtU/0/da"><img src="http://feedads.g.doubleclick.net/~a/dFiePBf59UpV8F4eQkdycuUtwtU/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/dFiePBf59UpV8F4eQkdycuUtwtU/1/da"><img src="http://feedads.g.doubleclick.net/~a/dFiePBf59UpV8F4eQkdycuUtwtU/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/CPvF1wYzKh8" height="1" width="1"/>
Published: Tue, 09 Mar 2010 20:00:00 PST by

New Genetic Test Helps Doctors Predict Frequency Of Genital Herpes Outbreaks
Molecular dermatology research and development innovator DermaGenoma, Inc. released The HerpesDX Genetic Test for Frequent Genital Herpes. The new screening test will help doctors assess patients' risk for developing frequent Genital Herpes (HSV-2) outbreaks. "Until now, physicians have been unable to give patients an answer to the most common question asked by recently infected Genital Herpes patients: Will I have frequent outbreaks?," says DermaGenoma CEO Andy Goren. "Using the HerpesDX genetic test, a doctor can finally assess a patient's risk for frequent outbreaks... <p><a href="http://feedads.g.doubleclick.net/~a/4Dmy1CUdwB2e1aKEtI12jAeIL3c/0/da"><img src="http://feedads.g.doubleclick.net/~a/4Dmy1CUdwB2e1aKEtI12jAeIL3c/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/4Dmy1CUdwB2e1aKEtI12jAeIL3c/1/da"><img src="http://feedads.g.doubleclick.net/~a/4Dmy1CUdwB2e1aKEtI12jAeIL3c/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/HC1QAnSQzUM" height="1" width="1"/>
Published: Tue, 09 Mar 2010 19:00:00 PST by

Millennium Announces First Clinical Data For TAK-700 Prostate Molecule At ASCO GU
Millennium: The Takeda Oncology Company today announced the presentation of safety, pharmacokinetic and efficacy data from the Phase I portion of a Phase I/II clinical trial evaluating TAK-700 in patients with metastatic castration resistant prostate cancer (mCRPC). These data were presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), held March 5-7, 2010 in San Francisco, CA... <p><a href="http://feedads.g.doubleclick.net/~a/dJFIU1OlXaLN7R_TmpZMu12ZUV8/0/da"><img src="http://feedads.g.doubleclick.net/~a/dJFIU1OlXaLN7R_TmpZMu12ZUV8/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/dJFIU1OlXaLN7R_TmpZMu12ZUV8/1/da"><img src="http://feedads.g.doubleclick.net/~a/dJFIU1OlXaLN7R_TmpZMu12ZUV8/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/XLyU8dOpuuY" height="1" width="1"/>
Published: Tue, 09 Mar 2010 17:00:00 PST by

ImmunoGen, Inc. Announces Orphan Drug Designation Granted To IMGN901 For Treatment Of Merkel Cell Carcinoma By US FDA And EU COMP
ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC... <p><a href="http://feedads.g.doubleclick.net/~a/BtmwaGJJ2zW3gRSvfppgS2uHp58/0/da"><img src="http://feedads.g.doubleclick.net/~a/BtmwaGJJ2zW3gRSvfppgS2uHp58/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/BtmwaGJJ2zW3gRSvfppgS2uHp58/1/da"><img src="http://feedads.g.doubleclick.net/~a/BtmwaGJJ2zW3gRSvfppgS2uHp58/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/ZvDyHFdCnPI" height="1" width="1"/>
Published: Tue, 09 Mar 2010 16:00:00 PST by

BG Medicine And Abbott To Develop Galectin-3 Test For The I-STAT(R) System
BG Medicine, Inc. announced that it has entered into an agreement with Abbott Laboratories (NYSE: ABT) to extend its current development and commercialization collaboration to include the development of a galectin-3 test for Abbott Point of Care's i-STAT® System. Galectin-3 is a novel biomarker that may play a role in detecting the development and progression of heart failure... <p><a href="http://feedads.g.doubleclick.net/~a/kkPIEdOgNB9Y-4G9g4zdvl9rNDk/0/da"><img src="http://feedads.g.doubleclick.net/~a/kkPIEdOgNB9Y-4G9g4zdvl9rNDk/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/kkPIEdOgNB9Y-4G9g4zdvl9rNDk/1/da"><img src="http://feedads.g.doubleclick.net/~a/kkPIEdOgNB9Y-4G9g4zdvl9rNDk/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/gARIAVX5nic" height="1" width="1"/>
Published: Tue, 09 Mar 2010 15:00:00 PST by

Vets Welcome Extension To UK Pet Travel Protection
The European Parliament has voted 618 votes to 17 for an extension to the transitional arrangements contained within the regulation on the non-commercial movement of pet animals (Reg. 998/2003) which afford the UK additional protection against rabies, ticks and tapeworms. The British Veterinary Association (BVA) and British Small Animal Veterinary Association (BSAVA) have been lobbying MEPs to support the extension and have strongly welcomed this decision... <p><a href="http://feedads.g.doubleclick.net/~a/tZb3n1Eae0ISsxGyHVvpM4XcvkE/0/da"><img src="http://feedads.g.doubleclick.net/~a/tZb3n1Eae0ISsxGyHVvpM4XcvkE/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/tZb3n1Eae0ISsxGyHVvpM4XcvkE/1/da"><img src="http://feedads.g.doubleclick.net/~a/tZb3n1Eae0ISsxGyHVvpM4XcvkE/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/eVLe5GIjpR0" height="1" width="1"/>
Published: Tue, 09 Mar 2010 13:00:00 PST by

The Royal Pharmaceutical Society Appoints New Chief Executive
The Royal Pharmaceutical Society today announced the appointment of Helen Gordon as Chief Executive of the new Professional Leadership Body. Mrs Gordon will join the Society on the 1st of July. Mrs Gordon comes to the Society from her current position as Chief Executive of the Royal College of Obstetricians and Gynaecologists. Prior to leading the RCOG for the past five years, Mrs Gordon was Chief Executive of Queen Mary's Sidcup NHS Trust from 2000-2005. RPSGB President, Steve Churton said: "I am delighted to welcome Helen to the Society at this pivotal time in its history... <p><a href="http://feedads.g.doubleclick.net/~a/PXqIllSqQLYjh32auY181EABlx8/0/da"><img src="http://feedads.g.doubleclick.net/~a/PXqIllSqQLYjh32auY181EABlx8/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/PXqIllSqQLYjh32auY181EABlx8/1/da"><img src="http://feedads.g.doubleclick.net/~a/PXqIllSqQLYjh32auY181EABlx8/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/0DlndovpYQ4" height="1" width="1"/>
Published: Tue, 09 Mar 2010 12:00:00 PST by

Link Between Hepatitis C And Insulin Resistance Surprises Scientists
Scientists in Australia found that when they studied insulin resistance in people with Hepatitis C little or none of it was in the liver and nearly all the insulin resistance occured in muscle, which surprised them because Hepatitis C is a liver disease that not only leads to cirrhosis and cancer, but also makes people three to four times more likely to develop Type 2 diabetes. You can read about the study that led to these findings in the March 2010 issue of the journal Gastroenterology, which is also available online... <p><a href="http://feedads.g.doubleclick.net/~a/WScqtJzswU1QN4DoZLMb9FLYFkU/0/da"><img src="http://feedads.g.doubleclick.net/~a/WScqtJzswU1QN4DoZLMb9FLYFkU/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/WScqtJzswU1QN4DoZLMb9FLYFkU/1/da"><img src="http://feedads.g.doubleclick.net/~a/WScqtJzswU1QN4DoZLMb9FLYFkU/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/v0JC1edw_qE" height="1" width="1"/>
Published: Tue, 09 Mar 2010 12:00:00 PST by

Dr Avijit Banerjee Confirmed For 2010 British Dental Conference And Exhibition
The BDA is proud to announce that the respected clinical expert Dr Avijit Banerjee has been confirmed to join the prestigious panel of speakers appearing at the 2010 British Dental Conference and Exhibition, to be held on the 20 - 22 May 2010 at the Liverpool Arena and Convention Centre (ACC). Dr Banerjee, Senior Lecturer and Honorary Consultant in Restorative Dentistry at King's College London (KCL) Dental Institute at Guy's Hospital, will be delivering a presentation titled Revolutions in caries management - minimal invasive dentistry in practice... <p><a href="http://feedads.g.doubleclick.net/~a/OHLuBls7XLtWnwHSfObVf1J2JKQ/0/da"><img src="http://feedads.g.doubleclick.net/~a/OHLuBls7XLtWnwHSfObVf1J2JKQ/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/OHLuBls7XLtWnwHSfObVf1J2JKQ/1/da"><img src="http://feedads.g.doubleclick.net/~a/OHLuBls7XLtWnwHSfObVf1J2JKQ/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/uMSfAJqv4cA" height="1" width="1"/>
Published: Tue, 09 Mar 2010 11:00:00 PST by